JP Palmer, GA Fleming, CJ Greenbaum, KC Herold, LD … - Diabetes, 2004 - Am Diabetes Assoc The underlying cause of type 1 diabetes, loss of β-cell function, has become the therapeutic target
for a number of interventions in patients with type 1 diabetes. Even though insulin therapies continue
to improve, it remains difficult to achieve normal glycemic control in type 1 diabetes, ... Cited by 27 - Related articles - All 2 versions
JP Palmer, GA Fleming, CJ Greenbaum, KC Herold, LD … - DIABETES, 2004 - Am Diabetes Assoc Page 1. ADA Workshop Report C-Peptide Is the Appropriate Outcome Measure for
Type 1 Diabetes Clinical Trials to Preserve -Cell Function Report of an ADA Workshop,
21–22 October 2001 Jerry P. Palmer, 1,2 G. Alexander ... Related articles - All 6 versions
[CITATION] C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to …
- ►diabetesjournals.org MW Steffes, S Sibley, M Jackson, W Thomas - Diabetes Care, 2003 - Am Diabetes Assoc In patients with type 1 diabetes, measurement of connecting peptide (C-peptide), cosecreted
with insulin from the islets of Langerhans, permits estimation of remaining β-cell secretion of
insulin. In this retrospective analysis to distinguish the incremental benefits of residual ... Cited by 113 - Related articles - BL Direct - All 5 versions
[CITATION] Homogeneity in patter of decline of β-cell function in IDDM
F Saudek, T Havrdova, P Boucek, L … - The Review of …, 2004 - pubmedcentral.nih.gov The destruction of pancreatic β-cells in type 1 diabetes mellitus is mediated by autoreactive
T-lymphocyte clones. We initiated a prospective randomized controlled trial of polyclonal rabbit
anti-T-cell globulin (ATG) in patients with type 1 diabetes within 4 weeks of diagnosis and ... Cited by 11 - Related articles - All 5 versions
[CITATION] Diabetes Study Group: Effects of oral insulin in relatives of patients with type 1 …
- ►eje-online.org [PDF] P Pozzilli, CA Mesturino, A Crino, TM Gross, LM Jeng … - European Journal of …, 2001 - EFES Objective: To evaluate sex differences in patients with insulin-dependent diabetes mellitus (type
1 dia- betes) by comparing the integrated parameters of metabolic control at the time of clinical
diagnosis and 3 months after intensive insulin therapy in pre-pubertal, pubertal and post- ... Cited by 15 - Related articles - BL Direct - All 8 versions
MD Jakkriss Bhumisawasdi, O Vanna, NS BSc - J Med Assoc Thai, 2006 - mat.or.th Correspondence to : Bhumisawasdi J, Bureau of inspector, Office of Permanent Secretary, Ministry
of Public Health, Nonthaburi 11000, Thailand. E-mail: jakkriss@health.moph. go.th ... The
Self-Reliant System for Alternative Care of Diabetes ... Jakkriss Bhumisawasdi MD, MPH* ... Cited by 2 - Related articles - View as HTML - BL Direct - All 5 versions
